Kit ELISA WISP-1 sandwich (human): quantitative determination of Hu WISP-1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu WISP-1.
Accession number
O95388
Dose range
61.44-15.000 pg/ml
Sensitivity of the dosage
50 pg/ml
Calibration range
50 pg/ml to 15000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA WISP-1 sandwich (human): quantitative determination of Hu WISP-1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu WISP-1.
Kit ELISA WISP-1 sandwich (human): quantitative determination of Hu WISP-1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu WISP-1.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
This gene encodes a member of the WNT1 (WISP)-inducible signaling pathway protein subfamily, which belongs to the connective tissue growth factor family (CTGF). WNT1 is part of a family of cysteine-rich glycosylated signalling proteins that mediate various developmental processes. The CTGF family members are characterized by four cysteine-rich domains: an insolinomimetic growth factor binding domain, a von Willebrand factor C module, a thrombospondin domain, and a C-terminal cystine node domain. This gene may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. It is expressed at a high level in fibroblast cells and overexpressed in colon tumours. The coded protein binds to decorine and biglycan, two members of a family of leucine-rich small proteoglycans present in the extracellular matrix of connective tissue, and is likely to prevent the inhibitory activity of decorine and biglycan in tumour cell proliferation. It also attenuates p53-mediated apoptosis in response to damage to DNA caused by activation of Akt kinase. It is 83% identical to mouse protein in amino acids. Alternative splicing of this gene generates 2 transcription variants.